HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

9.050

+0.2703.08%

Volume:864.00K

Turnover:7.80M

Market Cap:8.77B

PE:47.10

High:9.190

Open:9.000

Low:8.850

Close:8.780

52wk High:15.750

52wk Low:3.630

Shares:969.00M

HK Float Shares:969.00M

Volume Ratio:0.95

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.192

ROE:13.37%

ROA:5.22%

PB:4.18

PE(LYR):47.10

PS:9.87

Loading ...

Overview Company News Filings

Alphamab Oncology (09966) Announces January 2026 Monthly Return on Share Capital and Public Float

Bulletin Express

Assessing Alphamab Oncology’s Valuation After KN026 Phase III Trial Publication

Simply Wall St.

Soochow Securities Maintains "Buy" Rating on Alphamab-B (09966), Core Pipeline Products Under Regulatory Review

A Look At Alphamab Oncology (SEHK:9966) Valuation After KN035 Regulatory Milestone In Biliary Tract Cancer

Simply Wall St.

Alphamab Oncology's KN035 Accepted For Chinese Regulatory Review

MT Newswires Live

Is Alphamab Oncology (SEHK:9966) Quietly Reframing Its Immuno-Oncology Edge With JSKN033’s Phase II IND?

Simply Wall St.

BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Kn035 First-Line BTC Treatment

ALPHAMAB-B (09966): NDA for KN035 as First-line BTC Treatment Accepted by NMPA

China NMPA Accepts Alphamab Oncology NDA for KN035 in First-Line Biliary Tract Cancer

Alphamab Oncology - Nmpa Accepts Nda for Kn035 First-Line BTC Treatment

THOMSON REUTERS

Alphamab Oncology (SEHK:9966) Valuation Check After JSKN033 Phase II Trial Clearance In China

Simply Wall St.

Hong Kong Stock Movement | ALPHAMAB-B (09966) Surges Over 6% as Phase II Clinical Trial IND Application for JSKN033 Gets Accepted

Zhixiang Hong Kong Stock Repurchase Statistics | January 1

ALPHAMAB-B (09966) Spends HK$4.8335 Million on December 31 to Repurchase 500,000 Shares

Alphamab Oncology Files HKEX Disclosure on 500,000 Share Repurchase at HKD 4.83 Million

Alphamab-B (09966): Phase II Clinical Trial IND Application for JSKN033 Officially Accepted by CDE

Alphamab Oncology Wins CDE Approval for Phase II JSKN033 Cervical Cancer Trial

Alphamab Oncology - Ind Application for Jskn033 Phase Ii Trial Accepted by Cde

THOMSON REUTERS

Guojin Securities Initiates Coverage on ALPHAMAB-B (09966) with "Buy" Rating, Target Price HK$14.30

Alphamab Oncology (SEHK:9966): Assessing Valuation After New Breakthrough Therapy and IND Milestones

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/09966/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"09966","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"ALPHAMAB-B","latestPrice":9.05,"timestamp":1770624510009,"preClose":8.78,"halted":0,"volume":864000,"delay":0,"changeRate":0.03075170842824617,"floatShares":969000000,"shares":969000000,"eps":0.1921250439607674,"marketStatus":"Not Yet Opened","change":0.27,"latestTime":"02-09 16:08:30","open":9,"high":9.19,"low":8.85,"amount":7804060,"amplitude":0.038724,"askPrice":9.05,"askSize":1000,"bidPrice":9.02,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.26703120815911835,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770687000000},"marketStatusCode":0,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.78,"openAndCloseTimeList":[[1770600600000,1770609600000],[1770613200000,1770624000000]],"volumeRatio":0.9517586163373024,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","floatShares":969000000,"roa":"5.22%","roe":"13.37%","lyrEps":0.192125,"volumeRatio":0.9517586163373024,"shares":969000000,"dividePrice":0,"high":9.19,"amplitude":0.038724,"preClose":8.78,"low":8.85,"week52Low":3.63,"pbRate":"4.18","psRate":"9.87","week52High":15.75,"institutionHeld":0,"latestPrice":9.05,"committee":0.333333,"eps":0.1921250439607674,"divideRate":0,"volume":864000,"delay":0,"ttmEps":0.26703120815911835,"open":9,"prevYearClose":9.8,"prevWeekClose":8.78,"prevMonthClose":8.91,"prevQuarterClose":9.8,"fiveDayClose":8.73,"twentyDayClose":10.82,"sixtyDayClose":9.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09966\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-25","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post Market","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-15","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"Post Market","dateTimestamp":1723651200000,"actualEps":null},{"date":"2024-03-28","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711589400000,"name":null,"time":"","dateTimestamp":1711555200000,"actualEps":null},{"date":"2023-08-23","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692754200000,"name":null,"time":"","dateTimestamp":1692720000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09966\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09966\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.8,"buy":0.2,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.8,"analysts":5,"updateTime":1769356800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09966\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09966","date":"2026-02-06","current":33.89117,"percent":0.830357,"low":-53.868252,"twenty":-28.275738,"median":-18.037644,"eighty":-9.718873,"high":58.684884,"avg":-11.540731,"sd":26.539407,"marketCap":8504085839},"quantilePoints":[{"date":"2021-02-11","current":-12.75148,"twenty":-13.985937,"median":-13.308434,"eighty":-12.4075,"marketCap":13425729353},{"date":"2021-02-19","current":-12.177856,"twenty":-13.91226,"median":-13.001553,"eighty":-12.397536,"marketCap":12827368156},{"date":"2021-02-26","current":-11.599785,"twenty":-13.862484,"median":-12.840253,"eighty":-12.229028,"marketCap":12191609384},{"date":"2021-03-05","current":-11.735952,"twenty":-13.811366,"median":-12.792826,"eighty":-12.182412,"marketCap":12303802109},{"date":"2021-03-12","current":-10.416503,"twenty":-13.655112,"median":-12.676776,"eighty":-11.855965,"marketCap":10901393054},{"date":"2021-03-19","current":-11.099145,"twenty":-13.643022,"median":-12.430217,"eighty":-11.627018,"marketCap":11611946975},{"date":"2021-03-26","current":-22.011072,"twenty":-13.862484,"median":-12.571564,"eighty":-11.627018,"marketCap":11181874865},{"date":"2021-04-01","current":-21.10942,"twenty":-14.175129,"median":-12.741666,"eighty":-11.735952,"marketCap":10695706392},{"date":"2021-04-09","current":-20.73152,"twenty":-14.777253,"median":-12.792826,"eighty":-11.748164,"marketCap":10527417306},{"date":"2021-04-16","current":-19.149261,"twenty":-19.31421,"median":-12.840253,"eighty":-11.774987,"marketCap":9760767022},{"date":"2021-04-23","current":-23.785332,"twenty":-19.909587,"median":-13.001553,"eighty":-11.806946,"marketCap":12154211810},{"date":"2021-04-30","current":-25.947128,"twenty":-20.589267,"median":-13.334121,"eighty":-11.927996,"marketCap":13313536628},{"date":"2021-05-07","current":-24.693849,"twenty":-20.979864,"median":-13.571217,"eighty":-12.025342,"marketCap":12752573006},{"date":"2021-05-14","current":-33.151892,"twenty":-21.496231,"median":-13.651792,"eighty":-12.079033,"marketCap":17109390471},{"date":"2021-05-21","current":-38.938213,"twenty":-23.073114,"median":-13.857756,"eighty":-12.133289,"marketCap":20101196455},{"date":"2021-05-28","current":-35.61537,"twenty":-24.804272,"median":-14.027284,"eighty":-12.186968,"marketCap":18566998540},{"date":"2021-06-04","current":-34.269926,"twenty":-26.763069,"median":-14.635033,"eighty":-12.218282,"marketCap":17780895780},{"date":"2021-06-11","current":-40.856341,"twenty":-29.106826,"median":-15.098149,"eighty":-12.28389,"marketCap":21196699443},{"date":"2021-06-18","current":-38.644392,"twenty":-32.974194,"median":-18.282927,"eighty":-12.34924,"marketCap":19886528175},{"date":"2021-06-25","current":-46.948388,"twenty":-34.031567,"median":-19.040524,"eighty":-12.378554,"marketCap":24144584796},{"date":"2021-07-02","current":-45.207678,"twenty":-35.293135,"median":-19.996575,"eighty":-12.389531,"marketCap":23208748176},{"date":"2021-07-09","current":-44.614369,"twenty":-36.179596,"median":-20.566258,"eighty":-12.396986,"marketCap":22881205359},{"date":"2021-07-16","current":-48.447275,"twenty":-37.789288,"median":-20.67362,"eighty":-12.399738,"marketCap":24846462261},{"date":"2021-07-23","current":-48.36069,"twenty":-38.938213,"median":-20.957749,"eighty":-12.423271,"marketCap":24799670430},{"date":"2021-07-30","current":-39.104645,"twenty":-39.47908,"median":-21.103846,"eighty":-12.430217,"marketCap":20120487330},{"date":"2021-08-06","current":-38.378852,"twenty":-39.717213,"median":-21.649173,"eighty":-12.521428,"marketCap":19699360851},{"date":"2021-08-13","current":-38.508707,"twenty":-39.722433,"median":-22.932411,"eighty":-12.6217,"marketCap":19792944513},{"date":"2021-08-20","current":-31.697919,"twenty":-39.717213,"median":-24.391692,"eighty":-12.731852,"marketCap":16246123723},{"date":"2021-08-27","current":-23.511847,"twenty":-39.47908,"median":-24.785868,"eighty":-12.75148,"marketCap":16751475498},{"date":"2021-09-03","current":-27.638176,"twenty":-39.439714,"median":-25.947128,"eighty":-12.792826,"marketCap":19699360851},{"date":"2021-09-10","current":-30.382936,"twenty":-39.401539,"median":-26.640453,"eighty":-12.799389,"marketCap":21711409584},{"date":"2021-09-17","current":-26.992304,"twenty":-39.104645,"median":-26.783416,"eighty":-12.828856,"marketCap":19231442541},{"date":"2021-09-24","current":-24.472208,"twenty":-38.971499,"median":-26.752109,"eighty":-12.847091,"marketCap":17443994596},{"date":"2021-09-30","current":-23.082076,"twenty":-38.810991,"median":-26.645817,"eighty":-12.874922,"marketCap":16508157976},{"date":"2021-10-08","current":-22.481188,"twenty":-38.703179,"median":-26.190542,"eighty":-12.957107,"marketCap":16077673131},{"date":"2021-10-15","current":-22.073477,"twenty":-38.672506,"median":-25.693365,"eighty":-13.062755,"marketCap":15796922145},{"date":"2021-10-22","current":-23.032708,"twenty":-38.647454,"median":-24.836506,"eighty":-13.216108,"marketCap":16601741638},{"date":"2021-10-29","current":-20.929201,"twenty":-38.590118,"median":-24.43195,"eighty":-13.328983,"marketCap":15048252849},{"date":"2021-11-05","current":-19.049585,"twenty":-38.456765,"median":-23.785332,"eighty":-13.397234,"marketCap":13719364849},{"date":"2021-11-12","current":-21.352494,"twenty":-38.349074,"median":-23.685099,"eighty":-13.500511,"marketCap":15441304230},{"date":"2021-11-19","current":-23.559904,"twenty":-38.09836,"median":-23.566387,"eighty":-13.594759,"marketCap":17013509751},{"date":"2021-11-26","current":-24.796984,"twenty":-37.741225,"median":-23.751485,"eighty":-13.636547,"marketCap":17912582806},{"date":"2021-12-03","current":-23.432191,"twenty":-37.532346,"median":-23.768698,"eighty":-13.650686,"marketCap":16957993754},{"date":"2021-12-10","current":-21.429631,"twenty":-37.255577,"median":-23.601157,"eighty":-13.734345,"marketCap":15535211631},{"date":"2021-12-17","current":-17.822954,"twenty":-37.096113,"median":-23.511847,"eighty":-13.85618,"marketCap":12911653575},{"date":"2021-12-24","current":-17.909322,"twenty":-36.853053,"median":-23.44502,"eighty":-13.888948,"marketCap":12986612377},{"date":"2021-12-31","current":-17.535218,"twenty":-36.556554,"median":-23.429856,"eighty":-13.94459,"marketCap":12742996272},{"date":"2022-01-07","current":-15.893614,"twenty":-17.170858,"median":-16.499144,"eighty":-15.831692,"marketCap":11506176045},{"date":"2022-01-14","current":-16.943897,"twenty":-17.170858,"median":-16.521118,"eighty":-16.202208,"marketCap":12293243462},{"date":"2022-01-21","current":-16.029012,"twenty":-17.088796,"median":-16.543092,"eighty":-16.256367,"marketCap":11656093648},{"date":"2022-01-28","current":-12.285046,"twenty":-17.06511,"median":-16.479323,"eighty":-15.418562,"marketCap":8910727540},{"date":"2022-02-04","current":-12.601255,"twenty":-17.064989,"median":-16.436633,"eighty":-13.889332,"marketCap":9135603945},{"date":"2022-02-11","current":-12.640346,"twenty":-17.064,"median":-16.029012,"eighty":-13.029958,"marketCap":9182453196},{"date":"2022-02-18","current":-12.116498,"twenty":-16.945463,"median":-15.716538,"eighty":-12.878125,"marketCap":8845138588},{"date":"2022-02-25","current":-12.112309,"twenty":-16.943897,"median":-13.889332,"eighty":-12.601255,"marketCap":8863878289},{"date":"2022-03-04","current":-10.48082,"twenty":-16.543092,"median":-13.037325,"eighty":-12.112309,"marketCap":7672881063},{"date":"2022-03-11","current":-9.328946,"twenty":-16.517271,"median":-13.027408,"eighty":-11.794703,"marketCap":6819296495},{"date":"2022-03-18","current":-10.345437,"twenty":-16.499144,"median":-12.881139,"eighty":-11.440921,"marketCap":7532180310},{"date":"2022-03-25","current":-10.293471,"twenty":-16.459503,"median":-12.785641,"eighty":-10.48082,"marketCap":7494660109},{"date":"2022-04-01","current":-14.297066,"twenty":-16.413764,"median":-12.859655,"eighty":-10.48082,"marketCap":7260158854},{"date":"2022-04-08","current":-15.491011,"twenty":-16.409102,"median":-12.884734,"eighty":-10.570438,"marketCap":7869862117},{"date":"2022-04-14","current":-13.574781,"twenty":-16.284169,"median":-13.028683,"eighty":-10.933821,"marketCap":6884956846},{"date":"2022-04-22","current":-12.815632,"twenty":-16.132599,"median":-12.892105,"eighty":-11.273053,"marketCap":6378434136},{"date":"2022-04-29","current":-15.496239,"twenty":-15.992174,"median":-12.898894,"eighty":-11.449013,"marketCap":7588460611},{"date":"2022-05-06","current":-14.409179,"twenty":-15.928257,"median":-13.029958,"eighty":-11.46436,"marketCap":6997517449},{"date":"2022-05-13","current":-13.039318,"twenty":-15.893614,"median":-13.039318,"eighty":-11.477201,"marketCap":6218973282},{"date":"2022-05-20","current":-14.565659,"twenty":-15.738809,"median":-13.068955,"eighty":-11.584492,"marketCap":7044417700},{"date":"2022-05-27","current":-12.908885,"twenty":-15.694268,"median":-13.170134,"eighty":-11.742961,"marketCap":6237733383},{"date":"2022-06-02","current":-15.137652,"twenty":-15.684864,"median":-13.379031,"eighty":-11.784355,"marketCap":7353959356},{"date":"2022-06-10","current":-16.505757,"twenty":-15.940348,"median":-13.514449,"eighty":-11.948913,"marketCap":7964685112},{"date":"2022-06-17","current":-15.374218,"twenty":-15.902275,"median":-13.574781,"eighty":-12.01146,"marketCap":7410538389},{"date":"2022-06-24","current":-18.243922,"twenty":-16.040638,"median":-13.677347,"eighty":-12.020595,"marketCap":8828778309},{"date":"2022-06-30","current":-15.728498,"twenty":-16.132948,"median":-13.734552,"eighty":-12.075937,"marketCap":7598384736},{"date":"2022-07-08","current":-15.401573,"twenty":-16.213925,"median":-14.214649,"eighty":-12.114822,"marketCap":7448107658},{"date":"2022-07-15","current":-13.957754,"twenty":-16.132948,"median":-14.253329,"eighty":-12.158169,"marketCap":6687329953},{"date":"2022-07-22","current":-13.556788,"twenty":-16.052264,"median":-13.957754,"eighty":-12.241614,"marketCap":6499483606},{"date":"2022-07-29","current":-12.816298,"twenty":-15.984046,"median":-13.734552,"eighty":-12.282517,"marketCap":6151967864},{"date":"2022-08-05","current":-12.849025,"twenty":-15.951796,"median":-13.67889,"eighty":-12.241614,"marketCap":6151967864},{"date":"2022-08-12","current":-12.126293,"twenty":-15.942263,"median":-13.653572,"eighty":-12.13744,"marketCap":5813844439},{"date":"2022-08-19","current":-11.754194,"twenty":-15.910936,"median":-13.561425,"eighty":-12.101504,"marketCap":5579036505},{"date":"2022-08-26","current":-14.820088,"twenty":-15.819231,"median":-13.568103,"eighty":-12.114822,"marketCap":6978491791},{"date":"2022-09-02","current":-23.46609,"twenty":-15.942263,"median":-13.639619,"eighty":-12.119419,"marketCap":7805015717},{"date":"2022-09-09","current":-22.421914,"twenty":-16.132948,"median":-13.677347,"eighty":-12.124322,"marketCap":7429323023},{"date":"2022-09-16","current":-20.513842,"twenty":-16.411433,"median":-13.695704,"eighty":-12.133724,"marketCap":6734291539},{"date":"2022-09-23","current":-18.727552,"twenty":-16.482452,"median":-13.764182,"eighty":-12.145399,"marketCap":6029867738},{"date":"2022-09-30","current":-17.760163,"twenty":-16.512665,"median":-14.086201,"eighty":-12.162095,"marketCap":5729313583},{"date":"2022-10-07","current":-17.557368,"twenty":-16.549697,"median":-14.253329,"eighty":-12.200956,"marketCap":5663567362},{"date":"2022-10-14","current":-18.422453,"twenty":-17.040293,"median":-14.409179,"eighty":-12.26158,"marketCap":5879590661},{"date":"2022-10-21","current":-18.312429,"twenty":-17.110066,"median":-14.521212,"eighty":-12.266929,"marketCap":5804452122},{"date":"2022-10-28","current":-16.711302,"twenty":-17.217664,"median":-14.625046,"eighty":-12.279988,"marketCap":5287874668},{"date":"2022-11-04","current":-22.018013,"twenty":-17.339043,"median":-14.652332,"eighty":-12.287313,"marketCap":7034845695},{"date":"2022-11-11","current":-21.415614,"twenty":-17.446229,"median":-14.695745,"eighty":-12.339559,"marketCap":6903353252},{"date":"2022-11-18","current":-27.349007,"twenty":-17.693119,"median":-14.898563,"eighty":-12.519492,"marketCap":8785789555},{"date":"2022-11-25","current":-23.765769,"twenty":-17.972543,"median":-14.987518,"eighty":-12.558957,"marketCap":7574114079},{"date":"2022-12-02","current":-26.174182,"twenty":-18.335139,"median":-15.067608,"eighty":-12.605734,"marketCap":8485638974},{"date":"2022-12-09","current":-28.776484,"twenty":-18.700907,"median":-15.204594,"eighty":-12.62699,"marketCap":9415958197},{"date":"2022-12-16","current":-29.361916,"twenty":-19.228432,"median":-15.373796,"eighty":-12.660178,"marketCap":9585107147},{"date":"2022-12-23","current":-29.065003,"twenty":-19.518662,"median":-15.491011,"eighty":-12.748732,"marketCap":9491135508},{"date":"2022-12-30","current":-30.706351,"twenty":-20.691058,"median":-15.537108,"eighty":-12.776414,"marketCap":10148936979},{"date":"2023-01-06","current":-34.446644,"twenty":-21.092014,"median":-15.642909,"eighty":-12.803636,"marketCap":11502128576},{"date":"2023-01-13","current":-37.5558,"twenty":-22.093247,"median":-15.694268,"eighty":-12.816032,"marketCap":12780142863},{"date":"2023-01-20","current":-34.984086,"twenty":-22.45467,"median":-15.754226,"eighty":-12.83123,"marketCap":11802837820},{"date":"2023-01-27","current":-36.369324,"twenty":-23.121815,"median":-15.831629,"eighty":-12.841184,"marketCap":12272696014},{"date":"2023-02-03","current":-44.714918,"twenty":-23.888047,"median":-15.950281,"eighty":-12.849025,"marketCap":15167022486},{"date":"2023-02-10","current":-41.260502,"twenty":-24.093097,"median":-16.058077,"eighty":-12.878125,"marketCap":13911210300},{"date":"2023-02-17","current":-40.325712,"twenty":-25.009317,"median":-16.232327,"eighty":-12.884153,"marketCap":13467440762},{"date":"2023-02-24","current":-41.468197,"twenty":-25.82041,"median":-16.421267,"eighty":-12.885315,"marketCap":13679678367},{"date":"2023-03-03","current":-43.817626,"twenty":-27.026978,"median":-16.467172,"eighty":-12.898894,"marketCap":14547923115},{"date":"2023-03-10","current":-38.640155,"twenty":-41.544229,"median":-39.606335,"eighty":-38.921385,"marketCap":12734256308},{"date":"2023-03-17","current":-45.981837,"twenty":-36.747123,"median":-18.243922,"eighty":-13.756749,"marketCap":15300401897},{"date":"2023-03-24","current":-41.160417,"twenty":-37.327637,"median":-18.28036,"eighty":-13.766939,"marketCap":13853327317},{"date":"2023-03-31","current":-38.068943,"twenty":-38.013012,"median":-18.315502,"eighty":-13.778887,"marketCap":12714961980},{"date":"2023-04-06","current":-43.295967,"twenty":-38.403453,"median":-18.336928,"eighty":-13.781651,"marketCap":14451451477},{"date":"2023-04-14","current":-43.747506,"twenty":-38.561286,"median":-18.405859,"eighty":-13.793666,"marketCap":16284412612},{"date":"2023-04-21","current":-39.932363,"twenty":-38.703179,"median":-18.48348,"eighty":-13.816299,"marketCap":14856632359},{"date":"2023-04-28","current":-39.970681,"twenty":-39.225939,"median":-18.621321,"eighty":-13.840508,"marketCap":14760160721},{"date":"2023-05-05","current":-40.166061,"twenty":-39.290038,"median":-18.683461,"eighty":-13.852302,"marketCap":14856632359},{"date":"2023-05-12","current":-36.925364,"twenty":-39.290038,"median":-18.774651,"eighty":-13.85982,"marketCap":13563912401},{"date":"2023-05-19","current":-24.719387,"twenty":-39.117221,"median":-18.879869,"eighty":-13.865832,"marketCap":8952568071},{"date":"2023-05-25","current":-23.29845,"twenty":-39.108027,"median":-18.921163,"eighty":-13.869727,"marketCap":8403228460},{"date":"2023-06-02","current":-21.901518,"twenty":-39.071359,"median":-18.943448,"eighty":-13.885174,"marketCap":7872599797},{"date":"2023-06-09","current":-20.454824,"twenty":-38.924331,"median":-19.035121,"eighty":-13.891345,"marketCap":7341971135},{"date":"2023-06-16","current":-22.146741,"twenty":-38.853024,"median":-19.126864,"eighty":-13.899678,"marketCap":7911190973},{"date":"2023-06-23","current":-18.955124,"twenty":-38.789903,"median":-19.149261,"eighty":-13.900804,"marketCap":6734160121},{"date":"2023-06-30","current":-20.498364,"twenty":-38.749431,"median":-19.291559,"eighty":-13.923916,"marketCap":7216549814},{"date":"2023-07-07","current":-25.123882,"twenty":-38.726176,"median":-19.347276,"eighty":-13.932185,"marketCap":8827731391},{"date":"2023-07-14","current":-25.317769,"twenty":-38.687847,"median":-19.399951,"eighty":-13.94759,"marketCap":9020687268},{"date":"2023-07-21","current":-25.381576,"twenty":-38.649495,"median":-19.466605,"eighty":-13.957754,"marketCap":9001391680},{"date":"2023-07-28","current":-27.451279,"twenty":-38.644392,"median":-19.47828,"eighty":-13.964689,"marketCap":9724976220},{"date":"2023-08-04","current":-23.653749,"twenty":-38.640155,"median":-19.530791,"eighty":-13.983912,"marketCap":8393580666},{"date":"2023-08-11","current":-21.299887,"twenty":-38.508707,"median":-19.571912,"eighty":-14.027277,"marketCap":7515631424},{"date":"2023-08-18","current":-19.250306,"twenty":-38.506952,"median":-19.585154,"eighty":-14.027284,"marketCap":6743807915},{"date":"2023-08-25","current":-32.203663,"twenty":-38.501855,"median":-19.663677,"eighty":-14.080878,"marketCap":7563870394},{"date":"2023-09-01","current":-35.302101,"twenty":-38.378852,"median":-19.736206,"eighty":-14.101892,"marketCap":8326046109},{"date":"2023-09-08","current":-34.605021,"twenty":-38.304408,"median":-19.857796,"eighty":-14.114833,"marketCap":8065555675},{"date":"2023-09-15","current":-37.542629,"twenty":-38.132108,"median":-19.912369,"eighty":-14.137969,"marketCap":8818083597},{"date":"2023-09-22","current":-38.573862,"twenty":-38.378852,"median":-20.085413,"eighty":-14.152594,"marketCap":9020687268},{"date":"2023-09-29","current":-35.418957,"twenty":-38.378852,"median":-20.217001,"eighty":-14.161696,"marketCap":8297102728},{"date":"2023-10-06","current":-35.229903,"twenty":-38.322726,"median":-20.283173,"eighty":-14.166678,"marketCap":8248863758},{"date":"2023-10-13","current":-40.523415,"twenty":-38.502874,"median":-20.44317,"eighty":-14.173688,"marketCap":9474133580},{"date":"2023-10-20","current":-39.594032,"twenty":-38.521738,"median":-20.486571,"eighty":-14.206745,"marketCap":9242586527},{"date":"2023-10-27","current":-47.54977,"twenty":-38.64185,"median":-20.513842,"eighty":-14.216906,"marketCap":11094962950},{"date":"2023-11-03","current":-48.331086,"twenty":-38.735478,"median":-20.568945,"eighty":-14.224134,"marketCap":11307214415},{"date":"2023-11-10","current":-53.868252,"twenty":-39.004786,"median":-20.622682,"eighty":-14.233193,"marketCap":12600018794},{"date":"2023-11-17","current":-25.63055,"twenty":-39.106336,"median":-20.683961,"eighty":-14.258177,"marketCap":6049166756},{"date":"2023-11-24","current":-27.205215,"twenty":-39.004786,"median":-20.741333,"eighty":-14.276226,"marketCap":6473669686},{"date":"2023-12-01","current":-25.600638,"twenty":-38.896568,"median":-20.808578,"eighty":-14.289723,"marketCap":6117109736},{"date":"2023-12-08","current":-25.866704,"twenty":-38.821463,"median":-20.929201,"eighty":-14.323551,"marketCap":6155703488},{"date":"2023-12-15","current":-26.927511,"twenty":-38.76562,"median":-20.967194,"eighty":-14.351434,"marketCap":6445156630},{"date":"2023-12-22","current":-25.009304,"twenty":-38.735478,"median":-21.013037,"eighty":-14.35931,"marketCap":5982031603},{"date":"2023-12-29","current":-26.642107,"twenty":-38.71851,"median":-21.050342,"eighty":-14.361696,"marketCap":6406562878},{"date":"2024-01-05","current":-24.972539,"twenty":-38.687847,"median":-21.103846,"eighty":-14.368415,"marketCap":5962734727},{"date":"2024-01-12","current":-24.595768,"twenty":-38.649495,"median":-21.157012,"eighty":-14.402891,"marketCap":5875898784},{"date":"2024-01-19","current":-19.938246,"twenty":-38.644392,"median":-21.228449,"eighty":-14.409179,"marketCap":4756679968},{"date":"2024-01-26","current":-18.554521,"twenty":-38.640155,"median":-21.10942,"eighty":-14.411483,"marketCap":4409336197},{"date":"2024-02-02","current":-16.464276,"twenty":-38.588501,"median":-21.050342,"eighty":-14.423239,"marketCap":3907617418},{"date":"2024-02-09","current":-17.233111,"twenty":-38.573862,"median":-20.972717,"eighty":-14.434059,"marketCap":4110234617},{"date":"2024-02-16","current":-18.402278,"twenty":-38.534769,"median":-20.967194,"eighty":-14.439295,"marketCap":4390039321},{"date":"2024-02-23","current":-19.760229,"twenty":-38.507654,"median":-20.929201,"eighty":-14.453404,"marketCap":4689140902},{"date":"2024-03-01","current":-19.95108,"twenty":-38.503894,"median":-20.872963,"eighty":-14.464872,"marketCap":4737383092},{"date":"2024-03-08","current":-18.926824,"twenty":-38.428053,"median":-20.756308,"eighty":-14.480891,"marketCap":4496172140},{"date":"2024-03-15","current":-21.138772,"twenty":-38.336758,"median":-20.808578,"eighty":-14.489737,"marketCap":5017187796},{"date":"2024-03-22","current":-18.228539,"twenty":-38.306123,"median":-20.756308,"eighty":-14.50055,"marketCap":4322500255},{"date":"2024-03-28","current":-18.491125,"twenty":-38.279384,"median":-20.741333,"eighty":-14.518511,"marketCap":4370742445},{"date":"2024-04-05","current":-17.315482,"twenty":-38.241849,"median":-20.708906,"eighty":-14.534718,"marketCap":3946211170},{"date":"2024-04-12","current":-19.505885,"twenty":-38.177223,"median":-20.641249,"eighty":-14.539083,"marketCap":4447929950},{"date":"2024-04-19","current":-17.235745,"twenty":-38.132108,"median":-20.593675,"eighty":-14.549119,"marketCap":3926914294},{"date":"2024-04-26","current":-19.801056,"twenty":-38.068943,"median":-20.560672,"eighty":-14.563882,"marketCap":4505820578},{"date":"2024-05-03","current":-22.021106,"twenty":-38.043702,"median":-20.560672,"eighty":-14.565304,"marketCap":5007539358},{"date":"2024-05-10","current":-22.138266,"twenty":-38.000701,"median":-20.593675,"eighty":-14.571149,"marketCap":5046133110},{"date":"2024-05-17","current":-21.882428,"twenty":-37.938675,"median":-20.631965,"eighty":-14.596889,"marketCap":4980496851},{"date":"2024-05-24","current":-19.842196,"twenty":-37.865243,"median":-20.622682,"eighty":-14.620281,"marketCap":4505820578},{"date":"2024-05-31","current":-10.782036,"twenty":-37.809484,"median":-20.568945,"eighty":-14.569777,"marketCap":2450906469},{"date":"2024-06-07","current":-12.112976,"twenty":-37.717193,"median":-20.522014,"eighty":-14.537337,"marketCap":2750032849},{"date":"2024-06-14","current":-11.400893,"twenty":-37.653981,"median":-20.498364,"eighty":-14.489697,"marketCap":2585995802},{"date":"2024-06-21","current":-10.998512,"twenty":-37.601075,"median":-20.467365,"eighty":-14.43755,"marketCap":2489503422},{"date":"2024-06-28","current":-10.23542,"twenty":-37.550532,"median":-20.444852,"eighty":-14.405406,"marketCap":2315817136},{"date":"2024-07-05","current":-9.939046,"twenty":-37.533657,"median":-20.379051,"eighty":-14.358604,"marketCap":2248272470},{"date":"2024-07-12","current":-9.967061,"twenty":-37.482408,"median":-20.291848,"eighty":-14.273743,"marketCap":2257921708},{"date":"2024-07-19","current":-9.498347,"twenty":-37.402324,"median":-20.229766,"eighty":-14.215401,"marketCap":2151780089},{"date":"2024-07-26","current":-9.208575,"twenty":-37.327637,"median":-20.193614,"eighty":-14.154414,"marketCap":2093884661},{"date":"2024-08-02","current":-9.723471,"twenty":-37.32352,"median":-20.137385,"eighty":-14.085081,"marketCap":2209675518},{"date":"2024-08-09","current":-9.785633,"twenty":-37.276776,"median":-20.11618,"eighty":-13.968534,"marketCap":2238623232},{"date":"2024-08-16","current":-10.459398,"twenty":-37.131301,"median":-20.033441,"eighty":-13.92557,"marketCap":2450906469},{"date":"2024-08-23","current":-9.595269,"twenty":-37.054596,"median":-19.957659,"eighty":-13.885174,"marketCap":2257921708},{"date":"2024-08-30","current":-10.057543,"twenty":-37.014228,"median":-19.927086,"eighty":-13.851089,"marketCap":2382591163},{"date":"2024-09-06","current":-9.272587,"twenty":-36.98439,"median":-19.877354,"eighty":-13.778887,"marketCap":2197696119},{"date":"2024-09-13","current":-10.071667,"twenty":-36.894129,"median":-19.843829,"eighty":-13.713216,"marketCap":2380837463},{"date":"2024-09-20","current":-10.781754,"twenty":-36.769187,"median":-19.822249,"eighty":-13.694027,"marketCap":2563978806},{"date":"2024-09-27","current":-12.328923,"twenty":-36.726748,"median":-19.766991,"eighty":-13.667525,"marketCap":2949539529},{"date":"2024-10-04","current":-19.265835,"twenty":-36.672442,"median":-19.722789,"eighty":-13.668964,"marketCap":4588172601},{"date":"2024-10-10","current":-17.028579,"twenty":-36.626927,"median":-19.702627,"eighty":-13.673211,"marketCap":4029109553},{"date":"2024-10-18","current":-16.380704,"twenty":-36.583892,"median":-19.632926,"eighty":-13.677655,"marketCap":3855607228},{"date":"2024-10-25","current":-16.381742,"twenty":-36.520467,"median":-19.62099,"eighty":-13.687972,"marketCap":3855607228},{"date":"2024-11-01","current":-15.01467,"twenty":-36.416733,"median":-19.585154,"eighty":-13.696039,"marketCap":3536235131},{"date":"2024-11-08","current":-16.963396,"twenty":-36.363867,"median":-19.546761,"eighty":-13.701906,"marketCap":3977073562},{"date":"2024-11-15","current":-19.884819,"twenty":-36.278398,"median":-19.531887,"eighty":-13.707553,"marketCap":4612634955},{"date":"2024-11-22","current":-18.108329,"twenty":-36.210789,"median":-19.505972,"eighty":-13.721035,"marketCap":4198557078},{"date":"2024-11-29","current":-15.834641,"twenty":-36.188592,"median":-19.472152,"eighty":-13.744476,"marketCap":3668922584},{"date":"2024-12-06","current":-15.695605,"twenty":-36.08373,"median":-19.458841,"eighty":-13.760466,"marketCap":3628141712},{"date":"2024-12-13","current":-15.376556,"twenty":-35.741648,"median":-19.352594,"eighty":-13.764182,"marketCap":3551151967},{"date":"2024-12-20","current":-14.497713,"twenty":-35.546493,"median":-19.273329,"eighty":-13.764182,"marketCap":3329806452},{"date":"2024-12-27","current":-15.179905,"twenty":-35.418957,"median":-19.167386,"eighty":-13.764182,"marketCap":3483785941},{"date":"2025-01-03","current":-14.913703,"twenty":-35.25196,"median":-19.110348,"eighty":-13.764182,"marketCap":3426043632},{"date":"2025-01-10","current":-13.750925,"twenty":-34.933941,"median":-19.027831,"eighty":-13.754891,"marketCap":3146955808},{"date":"2025-01-17","current":-13.361676,"twenty":-34.446644,"median":-18.949286,"eighty":-13.704922,"marketCap":3060342346},{"date":"2025-01-24","current":-13.529011,"twenty":-34.269926,"median":-18.916804,"eighty":-13.694027,"marketCap":3118084654},{"date":"2025-01-28","current":-13.464721,"twenty":-34.170079,"median":-18.907538,"eighty":-13.67642,"marketCap":3118084654},{"date":"2025-02-07","current":-15.122505,"twenty":-33.185621,"median":-18.746316,"eighty":-13.668964,"marketCap":3483785941},{"date":"2025-02-14","current":-16.67621,"twenty":-32.529754,"median":-18.691754,"eighty":-13.668964,"marketCap":3839863509},{"date":"2025-02-21","current":-18.324448,"twenty":-31.716657,"median":-18.612372,"eighty":-13.668964,"marketCap":4234435950},{"date":"2025-02-28","current":-24.569098,"twenty":-30.791932,"median":-18.612372,"eighty":-13.668964,"marketCap":5658746225},{"date":"2025-03-07","current":-25.261571,"twenty":-30.029344,"median":-18.603349,"eighty":-13.668604,"marketCap":5841596868},{"date":"2025-03-14","current":-23.047481,"twenty":-28.794501,"median":-18.603349,"eighty":-13.668604,"marketCap":5331539810},{"date":"2025-03-21","current":-30.797536,"twenty":-28.744886,"median":-18.603349,"eighty":-13.668604,"marketCap":7121551371},{"date":"2025-03-28","current":44.165917,"twenty":-28.393605,"median":-18.522823,"eighty":-13.656111,"marketCap":7862577663},{"date":"2025-04-03","current":42.845017,"twenty":-28.217133,"median":-18.487302,"eighty":-13.645978,"marketCap":7612360993},{"date":"2025-04-11","current":34.734253,"twenty":-28.217133,"median":-18.487302,"eighty":-13.613827,"marketCap":6130308410},{"date":"2025-04-17","current":36.065457,"twenty":-28.158527,"median":-18.48348,"eighty":-13.574068,"marketCap":6380525080},{"date":"2025-04-25","current":37.556149,"twenty":-28.275738,"median":-18.491125,"eighty":-13.557411,"marketCap":6649989186},{"date":"2025-05-02","current":42.574598,"twenty":-28.217133,"median":-18.487302,"eighty":-13.526841,"marketCap":7554618684},{"date":"2025-05-09","current":39.514662,"twenty":-28.275738,"median":-18.491125,"eighty":-13.490846,"marketCap":7060873063},{"date":"2025-05-16","current":35.776948,"twenty":-28.275738,"median":-18.453232,"eighty":-13.440013,"marketCap":6445211106},{"date":"2025-05-23","current":47.38287,"twenty":-28.275738,"median":-18.402278,"eighty":-13.368618,"marketCap":8561549082},{"date":"2025-05-30","current":47.34521,"twenty":-28.275738,"median":-18.33304,"eighty":-13.277541,"marketCap":8592354976},{"date":"2025-06-06","current":42.147937,"twenty":-28.275738,"median":-18.299422,"eighty":-13.14218,"marketCap":7668652761},{"date":"2025-06-13","current":42.289865,"twenty":-28.275738,"median":-18.27405,"eighty":-13.070276,"marketCap":7697518456},{"date":"2025-06-20","current":35.964015,"twenty":-28.275738,"median":-18.27405,"eighty":-13.029979,"marketCap":6533268789},{"date":"2025-06-27","current":32.483216,"twenty":-28.217133,"median":-18.185823,"eighty":-12.946884,"marketCap":5917467313},{"date":"2025-07-04","current":34.066162,"twenty":-28.217133,"median":-18.046648,"eighty":-12.88485,"marketCap":6206124255},{"date":"2025-07-11","current":36.268142,"twenty":-28.217133,"median":-18.029621,"eighty":-12.840289,"marketCap":6600622076},{"date":"2025-07-18","current":45.76756,"twenty":-28.217133,"median":-18.029621,"eighty":-12.796764,"marketCap":8322941830},{"date":"2025-07-25","current":48.635945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.69525,"marketCap":8876728670},{"date":"2025-08-01","current":50.491081,"twenty":-28.217133,"median":-18.029621,"eighty":-12.5376,"marketCap":9158375422},{"date":"2025-08-08","current":48.602584,"twenty":-28.217133,"median":-18.029621,"eighty":-12.398637,"marketCap":8837880842},{"date":"2025-08-15","current":48.140623,"twenty":-28.217133,"median":-18.029621,"eighty":-12.315906,"marketCap":8740761273},{"date":"2025-08-22","current":57.950472,"twenty":-28.217133,"median":-18.029621,"eighty":-12.254489,"marketCap":10488913527},{"date":"2025-08-29","current":49.451084,"twenty":-28.217133,"median":-18.029621,"eighty":-12.194762,"marketCap":8993272154},{"date":"2025-09-05","current":39.453945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.124322,"marketCap":10032451550},{"date":"2025-09-12","current":47.42741,"twenty":-28.217133,"median":-18.029621,"eighty":-12.096265,"marketCap":12081674470},{"date":"2025-09-19","current":44.828603,"twenty":-28.217133,"median":-18.029621,"eighty":-12.019811,"marketCap":11411549439},{"date":"2025-09-26","current":46.934282,"twenty":-28.217133,"median":-18.029621,"eighty":-11.831972,"marketCap":11916571202},{"date":"2025-10-03","current":58.385068,"twenty":-28.158527,"median":-18.021599,"eighty":-11.755883,"marketCap":14859294164},{"date":"2025-10-10","current":49.909916,"twenty":-28.217133,"median":-18.029621,"eighty":-11.664242,"marketCap":12683815802},{"date":"2025-10-17","current":55.035469,"twenty":-28.217133,"median":-18.029621,"eighty":-11.470781,"marketCap":13975506079},{"date":"2025-10-24","current":45.261337,"twenty":-28.217133,"median":-18.029621,"eighty":-11.338351,"marketCap":11497678332},{"date":"2025-10-31","current":43.864804,"twenty":-28.217133,"median":-18.029621,"eighty":-11.156758,"marketCap":11159539015},{"date":"2025-11-07","current":36.144291,"twenty":-28.217133,"median":-18.029621,"eighty":-11.054596,"marketCap":9189637780},{"date":"2025-11-14","current":37.226268,"twenty":-28.217133,"median":-18.029621,"eighty":-10.962516,"marketCap":9491548883},{"date":"2025-11-21","current":37.509917,"twenty":-28.217133,"median":-18.029621,"eighty":-10.62574,"marketCap":9559414912},{"date":"2025-11-28","current":40.619308,"twenty":-28.217133,"median":-18.029621,"eighty":-10.506267,"marketCap":10389445551},{"date":"2025-12-05","current":41.722201,"twenty":-28.217133,"median":-18.029621,"eighty":-10.418991,"marketCap":10689886607},{"date":"2025-12-12","current":40.470968,"twenty":-28.217133,"median":-18.029621,"eighty":-10.328476,"marketCap":10388480751},{"date":"2025-12-19","current":41.091429,"twenty":-28.217133,"median":-18.029621,"eighty":-10.278072,"marketCap":10572604944},{"date":"2025-12-24","current":39.124027,"twenty":-28.217133,"median":-18.029621,"eighty":-10.261216,"marketCap":10097758342},{"date":"2026-01-02","current":35.829064,"twenty":-28.275738,"median":-18.037644,"eighty":-10.131708,"marketCap":9283735597},{"date":"2026-01-09","current":40.755473,"twenty":-28.275738,"median":-18.037644,"eighty":-10.049921,"marketCap":10586521438},{"date":"2026-01-16","current":37.910275,"twenty":-28.275738,"median":-18.037644,"eighty":-9.985778,"marketCap":9879461909},{"date":"2026-01-23","current":35.826131,"twenty":-28.275738,"median":-18.037644,"eighty":-9.870301,"marketCap":9327374332},{"date":"2026-01-30","current":32.996697,"twenty":-28.275738,"median":-18.037644,"eighty":-9.785633,"marketCap":8630000550},{"date":"2026-02-06","current":32.433,"twenty":-28.275738,"median":-18.037644,"eighty":-9.718873,"marketCap":8504085839}],"updateTime":1770674900096},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09966\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1114931724","title":"Alphamab Oncology (09966) Announces January 2026 Monthly Return on Share Capital and Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1114931724","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114931724?lang=en_us&edition=fundamental","pubTime":"2026-02-05 17:06","pubTimestamp":1770282390,"startTime":"0","endTime":"0","summary":"Alphamab Oncology (09966) reported its Monthly Return on Movements in Securities for the period ended January 31, 2026. The total authorized share capital remains 25,100,000,000 ordinary shares at a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"gpt_icon":0},{"id":"2607905552","title":"Assessing Alphamab Oncology’s Valuation After KN026 Phase III Trial Publication","url":"https://stock-news.laohu8.com/highlight/detail?id=2607905552","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607905552?lang=en_us&edition=fundamental","pubTime":"2026-01-30 00:28","pubTimestamp":1769704117,"startTime":"0","endTime":"0","summary":"Why the KN026 trial publication matters for Alphamab Oncology\nThe publication of Alphamab Oncology (SEHK:9966)'s Phase III anbenitamab, or KN026, gastric cancer trial in the Annals of Oncology, highlighting progression free and overall survival benefits versus standard care, gives investors fresh information on a key pipeline asset.\nBecause this study targets HER2 positive gastric or gastroesophageal junction cancer in patients who have already received trastuzumab containing therapy, it...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/assessing-alphamab-oncologys-valuation-after-kn026-phase-iii","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/assessing-alphamab-oncologys-valuation-after-kn026-phase-iii","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09966","BK1574","DCF","BK4134","III"],"gpt_icon":0},{"id":"1138237418","title":"Soochow Securities Maintains \"Buy\" Rating on Alphamab-B (09966), Core Pipeline Products Under Regulatory Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1138237418","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138237418?lang=en_us&edition=fundamental","pubTime":"2026-01-23 10:42","pubTimestamp":1769136134,"startTime":"0","endTime":"0","summary":"Soochow Securities has issued a research report maintaining a \"Buy\" rating on Alphamab-B (09966). Considering the company has multiple new ADC pipelines expected to complete preclinical R&D by 2025,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK0183","601555","09966","BK0009","BK0028","BK0188","BK1161","BK0276","BK0012"],"gpt_icon":0},{"id":"2603951436","title":"A Look At Alphamab Oncology (SEHK:9966) Valuation After KN035 Regulatory Milestone In Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603951436","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603951436?lang=en_us&edition=fundamental","pubTime":"2026-01-16 10:51","pubTimestamp":1768531870,"startTime":"0","endTime":"0","summary":"The latest development at Alphamab Oncology (SEHK:9966) involves China’s regulator formally accepting its new drug application for KN035, in combination with Gemcitabine and Oxaliplatin, for first-line treatment of unresectable or metastatic biliary tract cancer.\nSee our latest analysis for Alphamab Oncology.\nAfter the NMPA accepted the KN035 filing, Alphamab Oncology’s HK$10.28 share price sits alongside a 1-year total shareholder return of 216.31%, while the 90-day share price return of a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/a-look-at-alphamab-oncology-sehk9966-valuation-after-kn035-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/a-look-at-alphamab-oncology-sehk9966-valuation-after-kn035-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09966","DCF","BK1161","BK1574"],"gpt_icon":0},{"id":"2602670965","title":"Alphamab Oncology's KN035 Accepted For Chinese Regulatory Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2602670965","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602670965?lang=en_us&edition=fundamental","pubTime":"2026-01-12 11:50","pubTimestamp":1768189801,"startTime":"0","endTime":"0","summary":"Alphamab Oncology  said Chinese regulators accepted its KN035 combination therapy for review, according to a Hong Kong bourse filing Friday.Shares of the cancer therapy developer fell over 3% in late morning trade on Monday.The firm is seeking approval for KN035 in combination with chemotherapy drugs gemcitabine and oxaliplatin as a first-line treatment of unresectable or metastatic biliary tract cancer.KN035 is also known as envafolimab and Enweida.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2602300928","title":"Is Alphamab Oncology (SEHK:9966) Quietly Reframing Its Immuno-Oncology Edge With JSKN033’s Phase II IND?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300928","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602300928?lang=en_us&edition=fundamental","pubTime":"2026-01-10 04:28","pubTimestamp":1767990527,"startTime":"0","endTime":"0","summary":"In late 2025, Alphamab Oncology’s board announced that China’s Center for Drug Evaluation had accepted its Investigational New Drug application for a phase II trial of JSKN033, a high-concentration subcutaneous co-formulation combining a HER2-targeting bispecific ADC and a PD-L1 inhibitor with platinum-based chemotherapy, with or without bevacizumab, in advanced cervical cancer.\nThis acceptance marks a key progression in Alphamab Oncology’s immuno-oncology pipeline, highlighting its effort...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/is-alphamab-oncology-sehk9966-quietly-reframing-its-immuno-o","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/is-alphamab-oncology-sehk9966-quietly-reframing-its-immuno-o","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","09966","BK1574","IND"],"gpt_icon":0},{"id":"2602597377","title":"BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Kn035 First-Line BTC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2602597377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602597377?lang=en_us&edition=fundamental","pubTime":"2026-01-09 23:28","pubTimestamp":1767972491,"startTime":"0","endTime":"0","summary":"BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Kn035 First-Line BTC TreatmentJan 9 (Reuters) - Alphamab Oncology 9966.HK:NMPA ACCEPTS NDA FOR KN035 FIRST-LINE BTC TREATMENTFurther company coverage: 9966.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3Y91GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"1129139731","title":"ALPHAMAB-B (09966): NDA for KN035 as First-line BTC Treatment Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1129139731","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129139731?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:18","pubTimestamp":1767968298,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that China's National Medical Products Administration has formally accepted the New Drug Application for KN035 (Envafolimab Injection, brand name: ENVYDA®) in combination...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BTC","BTCmain","BK1161","XBTmain"],"gpt_icon":0},{"id":"2602371237","title":"China NMPA Accepts Alphamab Oncology NDA for KN035 in First-Line Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371237","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371237?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:16","pubTimestamp":1767968163,"startTime":"0","endTime":"0","summary":"Alphamab Oncology announced that the National Medical Products Administration  of China has formally accepted the new drug application  for KN035  in combination with the GEMOX regimen for the first-line treatment of unresectable or metastatic biliary tract cancer . The acceptance is based on results from a Phase III clinical trial  evaluating the efficacy and safety of this combination in Chinese patients with advanced BTC. The company cautioned that there is no guarantee of successful approval for this new indication.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on Jan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL1gVv5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2602371269","title":"Alphamab Oncology - Nmpa Accepts Nda for Kn035 First-Line BTC Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371269?lang=en_us&edition=fundamental","pubTime":"2026-01-09 22:15","pubTimestamp":1767968101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3Y91GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09966","BK1574","BK1161"],"gpt_icon":0},{"id":"2602311623","title":"Alphamab Oncology (SEHK:9966) Valuation Check After JSKN033 Phase II Trial Clearance In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2602311623","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602311623?lang=en_us&edition=fundamental","pubTime":"2026-01-09 02:39","pubTimestamp":1767897569,"startTime":"0","endTime":"0","summary":"Regulatory milestone and why it matters for Alphamab Oncology\nAlphamab Oncology (SEHK:9966) has drawn attention after regulators in China accepted its investigational new drug application for a phase II trial of JSKN033 in first line advanced cervical cancer.\nThe open label, multicenter study will test a high concentration subcutaneous co formulation. It combines a HER2 bispecific antibody drug conjugate with a PD L1 inhibitor, alongside platinum based chemotherapy with or without...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-valuation-check-after-jskn033-pha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-valuation-check-after-jskn033-pha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","DCF","09966"],"gpt_icon":0},{"id":"1129360197","title":"Hong Kong Stock Movement | ALPHAMAB-B (09966) Surges Over 6% as Phase II Clinical Trial IND Application for JSKN033 Gets Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1129360197","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129360197?lang=en_us&edition=fundamental","pubTime":"2026-01-08 10:16","pubTimestamp":1767838597,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) rose more than 6%, and as of the time of writing, it was up 6.76% to HK$10.89, with a turnover of HK$10.4175 million. Recently, ALPHAMAB-B announced that the Investigational New...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK1574","09966","BK1161"],"gpt_icon":0},{"id":"1174407833","title":"Zhixiang Hong Kong Stock Repurchase Statistics | January 1","url":"https://stock-news.laohu8.com/highlight/detail?id=1174407833","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174407833?lang=en_us&edition=fundamental","pubTime":"2026-01-01 09:13","pubTimestamp":1767230019,"startTime":"0","endTime":"0","summary":"A total of 58 companies conducted share buybacks on December 31, 2025. Among them, TENCENT (00700) executed the largest buyback by value, repurchasing 1.061 million shares for HK$635 million. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588545730.USD","03650","LU0072462343.USD","06098","LU2242644610.SGD","HK0000165453.HKD","LU2125910849.SGD","IE00B3M56506.USD","LU0143863784.USD","LU1282651048.USD","00345","BK1105","BK1160","BK1229","LU1226288253.USD","LU0633140727.USD","LU2039709279.SGD","LU2476274720.SGD","LU0175139822.USD","LU1008478684.HKD","LU0359201885.HKD","BK1608","GB00BDT5M118.USD","LU0828237940.HKD","HXXD.SI","LU0441854154.USD","SGXZ51526630.SGD","LU1718418525.SGD","LU0786609619.USD","LU1196710864.SGD","LU0326948709.USD","LU0648948544.HKD","LU1251922891.USD","LU1023057109.AUD","LU0196878994.USD","IE0008368411.USD","LU1770034418.SGD","LU2460026573.USD","81024","LU0828237510.HKD","LU0072913022.USD","01672","LU2362541273.HKD","BK1209","LU1993786604.SGD","LU0048388663.USD","09669","LU0449515922.USD","LU2317271919.USD","IE0032431581.USD","06868","IE00BPRC5H50.USD","BK1100","LU0231483743.USD","IE00B543WZ88.USD","LU0593848301.USD","LU0132412106.USD","BK1618","LU2251237488.HKD","LU0823040885.USD","SG9999001846.SGD","LU0543330566.HKD","LU0823397285.USD","SG9999003461.SGD","LU0862451753.SGD","LU0128522744.USD","IE0009570106.USD","LU0054450605.USD","LU0880133367.SGD","BK1574","LU1282651121.HKD","LU0878004406.USD","LU1880383366.USD","BK1518","LU0456842615.SGD","BK1191","BK1613","HK0000252160.HKD","02018","LU0106959298.USD","IE00BQXX3C00.GBP","BK1104","LU0502904849.HKD","LU1808992512.USD","SG9999013353.USD","09896","LU0264606111.USD","LU2279701549.SGD","LU0431992006.USD","BK1258","LU0700851271.USD","LU0540923850.HKD","BK1508","LU0181495838.USD","02299","LU0417516738.SGD","LU2257852520.SGD","LU1328277881.USD","LU0672654166.SGD","LU1102505929.USD","LU0203347892.USD","LU0117844026.USD","LU0588545490.SGD","LU0414403682.SGD","LU0348784397.USD","LU1226287792.SGD","SG9999002828.SGD","BK1542","01995","01868","LU0708995583.HKD","LU0823038988.USD","LU0107464264.USD","BK1233","BK1615","BK1526","BK1619","BK1144","LU0163747925.USD","LU0345776255.USD","06608","HK0000500386.USD","LU0972618739.USD","LU0873338254.USD","SG9999001051.SGD","BK1535","LU1044875133.USD","LU1725190679.HKD","LU0456846285.SGD","LU1568876335.HKD","LU0823426480.USD","LU0307460666.USD","IE0003851619.USD","00700","01024","HK0000320223.HKD","LU0164880469.USD","02598","BK1195","BK1589","SG9999001069.SGD","BK1221","LU0509642566.USD","LU2177674079.SGD","LU1102505762.USD","IE0032834883.USD","LU0329678337.USD","LU0326950275.SGD","LU0229945570.USD","LU2152927971.USD","LU0165289439.USD","LU0254981946.USD","LU0210526637.USD","LU0348783662.USD","02517","SG9999002463.SGD","BK1161","LU0173614495.USD","LU0651947912.USD","LU0259732245.USD","SG9999014914.USD","IE00BZ08YR35.GBP","TCHmain","BK1609","LU0823413587.USD","LU1794554557.SGD","LU1961090484.USD","06100","LU1868837565.USD","LU0516422366.SGD","LU1048596156.SGD","01458","LU1226287875.USD","BK1523","SG9999001903.USD","09959","LU0589944569.HKD","LU1366334651.USD","02678","09966","IE00B031J352.USD","LU0456827905.SGD","IE0034224299.USD","LU1981816686.USD","LU0588546209.SGD","LU1810669033.SGD","LU2449936058.SGD","LU1048484197.HKD","LU0898667661.SGD","BK1117","SG9999014906.USD","LU0531971595.HKD","LU0348767384.USD","BK1155","LU0797268264.HKD","LU1224709979.USD","LU1568876251.USD","LU2247934214.USD","LU0791591158.USD","HK0000306701.USD","BK1531","LU0127658192.USD","LU0289960550.SGD","LU1366334578.USD","LU1655091459.SGD","LU0516423091.SGD","BK1116","01651","LU0210527791.USD","BK1132","LU0868486357.SGD","LU0918141705.HKD","02652","LU1770036033.HKD","LU1733274390.USD","SG9999001689.USD","LU1880383440.USD","BK1095","LU0543330483.HKD","LU2488822045.USD","LU1048588211.SGD","02219","LU2293587155.HKD","BK1521","LU1323998911.USD","IE00B031HW06.USD","LU0359202008.SGD","LU2008162690.USD","LU2045819591.USD","LU0608807946.USD","LU1868838027.USD","BK1502","LU1282649141.HKD","SG9999014880.SGD","BK1193","01897","LU0823413660.USD","IE00B067MR52.USD","LU0650527681.SGD","BK1591","HK0000320264.USD","IE00BF5LJ272.USD","08017","LU1960683339.HKD","BK1128","LU1051769294.HKD","SG9999017495.SGD","XIACY","LU0823426308.USD","LU0831103253.SGD","LU0541501648.USD","02586","LU0348783233.USD","LU0541502299.USD","SGXZ31699556.SGD","LU2097828631.EUR","LU0577902454.USD","LU0918141887.USD","LU1917777945.USD","02391","LU2251237306.USD","SG9999001226.SGD","LU0328353924.USD","01516","SG9999002562.SGD","IE0003795394.USD","LU0096374516.USD","LU1152091168.USD","LU0890818403.SGD","LU0329678170.USD","LU1720050803.USD","01588","LU0737861699.HKD","LU1226288097.SGD","BK1506","LU0047713382.USD","LU0823397103.USD","LU0594300419.USD","BK1607","LU2476274308.USD","BK1585","LU0784639295.USD","LU1439102457.SGD","IE00B0JY6N72.USD","LU0611395673.USD","01810","LU0605514214.HKD","LU0051755006.USD","LU2133065610.SGD","LU2087589342.USD","SG9999007991.SGD","02621","LU0348766576.USD","LU0642271901.SGD","LU0244354667.USD","09922","LU0287142896.SGD","LU0985320562.USD","LU2462611646.USD","SG9999015952.SGD","SG9999006597.SGD","LU0128522157.USD","LU0345769128.USD","LU0791590937.USD","SG9999015945.SGD","BK1131","IE00BZ08YS42.EUR","IE00B97KM107.HKD","SGXZ90724238.SGD","LU0211331839.USD","BK1237","BK1566","LU1282649067.USD","BK1183","LU0396098781.USD","LU0348723411.USD","LU0572939691.SGD","SG9999014898.SGD","LU0011963245.USD","LU0314109678.HKD","LU0061477393.USD","LU0029875118.USD","LU0293314216.USD","LU2237443465.HKD","LU0348814723.USD","LU1688375341.USD","IE00BQXX3F31.USD","LU0577902371.SGD","02866","LU0228367735.SGD","LU0149721374.USD","LU0608807433.USD","LU0084288322.USD","LU0819123356.HKD","LU0048580855.USD","LU1211504680.USD","SG9999004220.SGD","BK1215","LU0561508036.HKD","LU1956131251.USD","LU0634319403.HKD","LU0348825331.USD","LU0572940350.SGD","LU1769817096.USD","LU0577902611.USD","LU0320764243.SGD","LU1152091754.HKD","LU0651946864.USD","BK1610","02509","BK1500","LU0348788117.USD","BK1604","LU1868837722.USD","IE0008369823.USD","LU0499858438.USD","LU2226246903.HKD","LU3063872942.SGD","SG9999006514.SGD","LU0345769631.USD","BK1142","IE00BGV7N243.SGD","LU0862451837.USD","LU0203345920.USD","LU2778985437.USD","SGXZ99366536.SGD","LU0577902538.SGD","LU2106854487.HKD","IE0031814852.USD","LU0192582467.USD","LU1804176565.USD","LU0164872284.USD","LU1235295612.USD","LU0140636845.USD","SG9999000327.SGD","LU0149534421.HKD","LU0067412154.USD","LU1814569148.SGD","LU2362541513.USD","LU0359201612.USD","LU0106259558.USD","IE00B8L5B284.USD","LU0683595622.HKD","LU0823039010.USD","LU1675838814.USD","LU0516422440.USD","LU0607220059.USD","02142","LU1282649810.SGD","BK1590","IE00B8HQ1Z84.USD","LU0169518387.USD","LU2362540622.SGD","HK0000306685.HKD","LU0348805143.USD","LU1515016050.SGD","LU0577902298.EUR","LU2097828714.EUR","LU0823041008.USD","LU1734074674.USD","LU1316542783.SGD","LU1224444064.USD","SG9999000418.SGD","LU1719994722.HKD","LU0261950983.USD","LU0106252389.USD","LU0029874905.USD","LU0164865239.USD","LU0871576103.HKD","LU0572944931.SGD","BK1253","LU0531970944.HKD","LU0737861772.HKD","BK1109","LU0049853897.USD","LU1226288170.HKD","LU1226287529.USD","BK1124","LU0070217475.USD","LU0886674414.USD","LU1242518857.USD","BK1167","BK1586","IE00BQXX3D17.EUR","LU2097828557.USD","LU1044876610.USD","LU0370786039.SGD","BK1549","09886","LU2125910500.SGD","SGXZ81514606.USD","LU0143863198.USD","LU2097828805.USD","IE0001KFT4U8.USD","IE0003895053.USD","IE00B5MMRT66.SGD","SG9999018857.SGD","LU0261947096.USD","01600","LU0738912210.USD","06609","03798","LU1629966141.USD","SG9999018865.SGD","BK1583","LU0417516902.SGD","LU0449509016.USD","LU0979878070.USD","LU1439103000.SGD","LU1044874839.SGD","LU2237443895.HKD","02121","IE00B29SXG58.USD","LU0320764755.SGD","LU0828238088.HKD","LU0588545904.SGD","BK1517","06078","LU1481107354.HKD","SG9999001093.SGD","LU1046422090.SGD","02038","BK1587","LU2237443978.SGD","LU0455707207.USD","LU0054237671.USD","00314","02869","LU0488056044.USD","SG9999000459.SGD","LU0188438112.USD","LU0327786744.USD","LU0633140560.USD","LU0348827113.USD","IE00B031HY20.USD","LU0228659784.USD","BK1247","LU1813983027.USD","LU2237443622.USD","LU2023250504.SGD","SG9999015986.USD","00909","81810","LU0516423174.USD","LU0882747503.HKD","LU1733274473.HKD","LU0819121731.USD","LU1883866441.USD","LU2051468812.USD","LU0117841782.USD","IE00B0169N27.USD","LU0048597586.USD","SG9999014674.SGD","LU0210533765.USD","LU0594300179.USD","LU1769817179.HKD","LU1303224171.USD","LU0214875030.USD","LU0320764599.SGD","01274","LU1974910355.USD","BK1516","LU0417516571.SGD","BK1515","LU0499858602.USD","LU1105468828.SGD","LU2498475776.HKD","LU1328615791.USD","LU0708995153.HKD","LU1188198961.HKD","LU1807302812.USD","LU0821914370.USD","LU0251144936.SGD","LU0039217434.USD","06887","LU0501845795.SGD","02419","LU0878005551.USD","09878","BK1249","LU1951186391.HKD","IE00B0169L03.USD","LU0052750758.USD","06831","BK1575","LU0315178854.USD","02416","LU1051768304.USD","LU1282648689.USD","LU0675040207.SGD","LU0348735423.USD","LU2265009873.SGD","LU0043850808.USD","BK1246","LU2097828474.EUR","HK0000252152.HKD","BK1504","LU0269904917.USD","02886","LU0049112450.USD","LU0080751232.USD","LU1242518931.SGD","LU1831875114.USD","LU0865486749.SGD","LU2399975544.HKD","LU1196710195.USD","LU0235996351.USD","LU0384037296.USD","09857","LU1504937902.USD","LU0345775950.USD","LU0348816934.USD","LU0469268626.HKD","IE00BZ08YT58.USD","LU2237443382.USD","LU1642822792.SGD","SG9999015978.USD","IE0008368742.USD","HTCD.SI","LU0211977185.USD","LU2237443549.SGD","LU1196710351.USD","LU0856984785.SGD","LU0516422952.EUR","LU1785774172.SGD","LU0463099449.HKD"],"gpt_icon":1},{"id":"1152610011","title":"ALPHAMAB-B (09966) Spends HK$4.8335 Million on December 31 to Repurchase 500,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1152610011","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152610011?lang=en_us&edition=fundamental","pubTime":"2025-12-31 17:13","pubTimestamp":1767172408,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) announced that on December 31, 2025, it expended HK$4.8335 million to repurchase 500,000 of its own shares.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"2595722276","title":"Alphamab Oncology Files HKEX Disclosure on 500,000 Share Repurchase at HKD 4.83 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722276","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595722276?lang=en_us&edition=fundamental","pubTime":"2025-12-31 16:57","pubTimestamp":1767171473,"startTime":"0","endTime":"0","summary":"Alphamab Oncology has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 500,000 shares at a total aggregate price of HKD 4,833,510. The repurchased shares are being held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL7dVmhB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"gpt_icon":0},{"id":"1181201856","title":"Alphamab-B (09966): Phase II Clinical Trial IND Application for JSKN033 Officially Accepted by CDE","url":"https://stock-news.laohu8.com/highlight/detail?id=1181201856","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181201856?lang=en_us&edition=fundamental","pubTime":"2025-12-29 12:20","pubTimestamp":1766982019,"startTime":"0","endTime":"0","summary":"Alphamab-B (09966) announced that the Investigational New Drug (IND) application for a Phase II clinical trial (Study Number: JSKN033-202) of JSKN033 has been officially accepted by the Center for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1223082196.USD","CDE","09966","LU1223083913.SGD","BK4017","IND","BK1574","LU1223082519.USD"],"gpt_icon":0},{"id":"2595798206","title":"Alphamab Oncology Wins CDE Approval for Phase II JSKN033 Cervical Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2595798206","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595798206?lang=en_us&edition=fundamental","pubTime":"2025-12-29 12:11","pubTimestamp":1766981500,"startTime":"0","endTime":"0","summary":"Alphamab Oncology announced that its Investigational New Drug  application for a phase II clinical trial of JSKN033 has been officially accepted by the Center for Drug Evaluation . The trial will evaluate JSKN033, a high-concentration subcutaneous co-formulation of an anti-HER2 bispecific antibody-drug conjugate and a PD-L1 immune checkpoint inhibitor, in combination with platinum-based chemotherapy with or without bevacizumab as a first-line treatment for advanced cervical cancer. The company cautioned that successful development or marketing of JSKN033 is not guaranteed. No other beneficiary organizations were mentioned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphamab Oncology published the original content used to generate t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL3VT9Lk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"2595794206","title":"Alphamab Oncology - Ind Application for Jskn033 Phase Ii Trial Accepted by Cde","url":"https://stock-news.laohu8.com/highlight/detail?id=2595794206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595794206?lang=en_us&edition=fundamental","pubTime":"2025-12-29 12:11","pubTimestamp":1766981488,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XX03D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09966","BK1574"],"gpt_icon":0},{"id":"1117789066","title":"Guojin Securities Initiates Coverage on ALPHAMAB-B (09966) with \"Buy\" Rating, Target Price HK$14.30","url":"https://stock-news.laohu8.com/highlight/detail?id=1117789066","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117789066?lang=en_us&edition=fundamental","pubTime":"2025-12-22 10:08","pubTimestamp":1766369307,"startTime":"0","endTime":"0","summary":"Guojin Securities released a research report forecasting ALPHAMAB-B's (09966) revenue for 2025/2026/2027 at RMB443 million/RMB486 million/RMB550 million, representing year-on-year changes of...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1161","BK1574"],"gpt_icon":0},{"id":"2592149879","title":"Alphamab Oncology (SEHK:9966): Assessing Valuation After New Breakthrough Therapy and IND Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2592149879","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592149879?lang=en_us&edition=fundamental","pubTime":"2025-12-20 21:13","pubTimestamp":1766236431,"startTime":"0","endTime":"0","summary":"Alphamab Oncology (SEHK:9966) just cleared two important regulatory hurdles, with US breakthrough therapy status for JSKN003 and China IND acceptance for JSKN027, tightening investor focus on how these ADC assets might reshape its valuation.\nSee our latest analysis for Alphamab Oncology.\nThe latest catalysts come after a powerful run, with the share price last closing at HK$10.91 and a year to date share price return of 218.08 percent. The 5 year total shareholder return of negative 27.56...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-assessing-valuation-after-new-bre","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/alphamab-oncology-sehk9966-assessing-valuation-after-new-bre","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IND","BK1574","DCF","BK1161","09966"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":107,"code":"91000000","status":"200"}]}}